rosiglitazone has been researched along with Brain Edema in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al Rouq, F; El Eter, E | 1 |
| Neuhaus, W; Thal, SC | 1 |
| Liu, ZJ; Shao, ZQ | 1 |
| Chen, G; Chen, J; Gu, C; Li, J; Wang, Y; Wu, C; Yan, F | 1 |
| Chapman, AC; Cipolla, MJ; Roberts, TJ | 1 |
| Allahtavakoli, M; Djahanguiri, B; Parviz, M; Sadr, SS; Shabanzadeh, AP | 1 |
| Hyong, A; Jadhav, V; Lee, S; Rowe, J; Tang, J; Tong, W; Zhang, JH | 1 |
1 review(s) available for rosiglitazone and Brain Edema
| Article | Year |
|---|---|
The blood-brain barrier as a target in traumatic brain injury treatment.
Topics: Blood-Brain Barrier; Brain Edema; Brain Injuries; Cell Hypoxia; Humans; Hypoglycemic Agents; Inflammation; Myosin-Light-Chain Kinase; Neurodegenerative Diseases; Neuroprotective Agents; Peroxisome Proliferator-Activated Receptors; Pioglitazone; Receptors, Glucocorticoid; Rosiglitazone; Thiazolidinediones | 2014 |
6 other study(ies) available for rosiglitazone and Brain Edema
| Article | Year |
|---|---|
PPAR-γ activator induces neuroprotection in hypercholesterolemic rats subjected to global cerebral ischemia/reperfusion injury: in vivo and in vitro inhibition of oxidative stress.
Topics: Animals; Brain Edema; Brain Ischemia; Dose-Response Relationship, Drug; Glutathione; Hypercholesterolemia; Interleukin-6; Lipid Peroxidation; Male; Neuroprotective Agents; Oxidative Stress; Peroxidase; PPAR gamma; Rats; Rats, Wistar; Reperfusion Injury; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2014 |
Neuroinflammation and neuronal autophagic death were suppressed via Rosiglitazone treatment: New evidence on neuroprotection in a rat model of global cerebral ischemia.
Topics: Animals; Autophagy; Brain Edema; Brain Ischemia; Cerebral Infarction; Disease Models, Animal; Female; Inflammation; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Recovery of Function; Rosiglitazone; Thiazolidinediones | 2015 |
Rosiglitazone attenuates early brain injury after experimental subarachnoid hemorrhage in rats.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries; Caspase 3; Cyclin D1; Disease Models, Animal; In Situ Nick-End Labeling; Male; Matrix Metalloproteinase 9; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Rosiglitazone; Subarachnoid Hemorrhage; Thiazolidinediones | 2015 |
PPAR-gamma agonist rosiglitazone reverses increased cerebral venous hydraulic conductivity during hypertension.
Topics: Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Brain Edema; Capillary Permeability; Cerebral Veins; Cerebrovascular Circulation; Chronic Disease; Cyclic N-Oxides; Disease Models, Animal; Female; Hydrostatic Pressure; Hypertension; NG-Nitroarginine Methyl Ester; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Spin Labels; Thiazolidinediones; Time Factors | 2009 |
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke.
Topics: Animals; Behavior, Animal; Brain Edema; Brain Infarction; Dose-Response Relationship, Drug; Fibrinolytic Agents; PPAR gamma; Rats; Rosiglitazone; Stroke; Thiazolidinediones; Time Factors | 2006 |
Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries; Disease Models, Animal; Drug Administration Schedule; Inflammation; Intraoperative Complications; Male; Neuroprotective Agents; Neurosurgical Procedures; Peroxidase; Postoperative Complications; PPAR gamma; Random Allocation; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2008 |